Department of Cellular and Molecular Physiology, The Pennsylvania State University College of Medicine, 500 University Drive, Hershey, PA 17033, USA.
Am J Physiol Endocrinol Metab. 2010 Aug;299(2):E241-8. doi: 10.1152/ajpendo.00151.2010. Epub 2010 May 18.
Eukaryotic initiation factor 2B (eIF2B) is a guanine nucleotide exchange factor (GEF) whose activity is both tightly regulated and rate-controlling with regard to global rates of protein synthesis. Skeletal muscle eIF2B activity and expression of its catalytic epsilon-subunit (eIF2Bepsilon) have been implicated as potential contributors to the altered rates of protein synthesis in a number of physiological conditions and experimental models. The objective of this study was to directly examine the effects of exogenously expressed eIF2Bepsilon in vivo on GEF activity and protein synthetic rates in rat skeletal muscle. A plasmid encoding FLAG-eIF2Bepsilon was transfected into the tibialis anterior (TA) of one leg, while the contralateral TA received a control plasmid. Ectopic expression of eIF2Bepsilon resulted in increased GEF activity in TA homogenates of healthy rats, demonstrating that the expressed protein was catalytically active. In an effort to restore a deficit in eIF2B activity, we utilized an established model of chronic sepsis in which skeletal muscle eIF2B activity is known to be impaired. Ectopic expression of eIF2Bepsilon in the TA rescued the sepsis-induced deficit in GEF activity and muscle protein synthesis. The results demonstrate that modulation of eIF2Bepsilon expression may be sufficient to correct deficits in skeletal muscle protein synthesis associated with sepsis and other muscle-wasting conditions.
真核起始因子 2B(eIF2B)是一种鸟嘌呤核苷酸交换因子(GEF),其活性受到严格调节,并且对蛋白质合成的总体速率具有速率控制作用。骨骼肌 eIF2B 的活性及其催化 ε-亚基(eIF2Bε)的表达已被认为是许多生理条件和实验模型中蛋白质合成速率改变的潜在因素。本研究的目的是直接研究外源性表达的 eIF2Bε 在体内对大鼠骨骼肌中 GEF 活性和蛋白质合成速率的影响。将编码 FLAG-eIF2Bε 的质粒转染到一条腿的比目鱼肌(TA)中,而对侧 TA 则接受对照质粒。在健康大鼠的 TA 匀浆中,eIF2Bε 的异位表达导致 GEF 活性增加,表明表达的蛋白具有催化活性。为了恢复 eIF2B 活性的不足,我们利用了慢性败血症的既定模型,已知该模型中骨骼肌 eIF2B 活性受损。在 TA 中异位表达 eIF2Bε 可挽救败血症引起的 GEF 活性和肌肉蛋白质合成不足。结果表明,调节 eIF2Bε 的表达可能足以纠正与败血症和其他肌肉消耗性疾病相关的骨骼肌蛋白质合成不足。